Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease crawled date : 2021 - 05 - 17 save search
Spero Therapeutics Awarded up to $23 Million by the National Institute of Allergy and Infectious Diseases to Support the Development of SPR206
Published: 2021-05-17 (Crawled : 20:00) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: 0.52%
H: 6.83%
C: 2.45%
disease infectious disease
Ironwood Pharmaceuticals to Present New Linaclotide Data and Unveil Findings From GI Disease Surveys at Digestive Disease Week® 2021
Published: 2021-05-17 (Crawled : 13:00) - biospace.com/
IRWD | $7.94 4.47% 4.28% 2.5M
|
Health Technology
|
| O: 0.17%
H: 1.71%
C: 1.24%
disease
Savara to Present at the Oppenheimer Rare & Orphan Disease Virtual Summit
Published: 2021-05-17 (Crawled : 13:00) - biospace.com/
SVRA | $4.81 0.42% 0.42% 880K
|
Health Technology
|
| O: -0.64%
H: 3.87%
C: 3.87%
disease rare
Salix Will Feature New Data At Digestive Disease Week® 2021
Published: 2021-05-17 (Crawled : 12:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -0.14%
H: 0.83%
C: 0.76%
disease
Rezolute to Present at the Oppenheimer Rare and Orphan Disease Summit
Published: 2021-05-17 (Crawled : 12:00) - biospace.com/
RZLT 4 | $3.44 4.24% 4.07% 340K
|
Technology Services
|
| O: 2.58%
H: 0.56%
C: -3.63%
disease rare
Clene Nanomedicine Receives Catalyst Award for Healthy Longevity from U.S. National Academy of Medicine to Accelerate the Development of CNM-Au8 for Neurodegenerative Diseases Associated with Aging
Published: 2021-05-17 (Crawled : 11:00) - globenewswire.com
CLNN S | $0.3492 5.85% 5.53% 1.2M
|
|
| O: -0.14%
H: 23.18%
C: 17.83%
disease cnm-au8 neurodegenerative
Allergy Diagnostics Market will Accelerate at a CAGR of almost 12% through 2021-2025|Environmental Factors Leading To Allergic Diseases to upheave Growth|Technavio
Published: 2021-05-17 (Crawled : 10:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.39%
H: 0.12%
C: -1.72%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.26%
H: 0.3%
C: -1.07%
disease growth diagnostics diagnostic
4D pharma to Present Additional Data from Phase II Study of Blautix for the Treatment of Irritable Bowel Syndrome at Digestive Disease Week (DDW) 2021
Published: 2021-05-17 (Crawled : 07:00) - 4dpharmaplc.com
LBPS | $1.65 -0.61%
|
Manufacturing
| Email alert
Add to watchlist
disease treatment syndros
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.